Thinking of microdosing weight-loss drugs? A doctor explains the dangers
- Dr Ambrish Mithal cautions that microdosing GLP-1 drugs like semaglutide can be risky and lacks medical endorsement.
- This trend involves patients taking smaller doses of semaglutide and tirzepatide, hoping to lose weight or reduce side.
- The British Medical Journal highlighted the misuse of weight-loss drugs, raising alarms about their unregulated use in India.
Source: firstpost.com
Get 100 stories a day on the app
Read, watch & listen · Free on iOS & Android
